Latest Breaking News On - ஜப்பான் நீரிழிவு நோய் சமூகம் - Page 1 : vimarsana.com

Press release content from Business Wire. The AP news staff was not involved in its creation. Poxel Announces its Participation at the 64th Annual Meeting of the Japan Diabetes Society May 11, 2021 GMT LYON, France (BUSINESS WIRE) May 11, 2021 POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH) today announced its participation at the 64 th Annual Meeting of the Japan Diabetes Society (May 20-22, 2021). Three presentations on Imeglimin will be included in an oral session for large clinical studies in the afternoon (2:30 pm to 3:40 pm JST) of May 20. These presentations will be focused on the analysis and interpretation of clinical data derived from Phase 2 and Phase 3 (TIMES program) trials with Imeglimin, Poxel’s novel antidiabetic investigational drug, where Japanese patients with type 2 diabetes (T2DM) were en

United statesSouth koreaSumitomo dainippon pharmaArthur rouillValeria fisherCatherine davidWorld health organizationMeeting of the japan diabetes societyDevices agencyTrophic communicationsAnnual meetingJapan diabetes societyLong term phaseSoutheast asianMedical devices agencyEuronext paris